The discussion was on Tuesday, December 7, 2021
Optimizing Immunotherapy in Triple-Negative Breast Cancer: Novel Predictive Biomarkers and Blood-Basted Efficacy Monitoring
Advertisement
Speakers –
Adam Brufsky, MD, Ph.D. – Interactive Case Studies
Speaks about Navigating Treatment Decision Points in Management of TNBC: Interactive Case Studies
Giampaolo Bianchini, MD
Speaks about Harnessing the TNBC Microenvironment to Integrate Novel Predictive Biomarkers
Hope Rugo, MD
Speaks about Callenges and Oppotrunites for Optimizing Immunotherapies for TNBC
Advertisement